Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,855 papers from all fields of science
Search
Sign In
Create Free Account
Myozyme
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
alglucosidase alfa
alglucosidase alfa 50 MG Injection [Myozyme]
alglucosidase alfa Injection [Myozyme]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
[Effect of proprotein convertase subtilisin/kexin type 9 inhibitor on blood lipid profile in patients with extremely high risk atherosclerotic cardiovascular disease].
Jing Wang
,
Songbai Deng
,
Ya-jie Liu
,
Q. She
,
Jianlin Du
Zhonghua wei zhong bing ji jiu yi xue
2020
Corpus ID: 218562994
OBJECTIVE To investigate the lowering effect on lipid and safety of proprotein convertase subtilisin/kexin type 9 (PCSK9…
Expand
2020
2020
Pre/post effectiveness evaluation of updated additional risk minimisation measures for an orphan disease: Myozyme (alglucosidase alfa) Safety Information Packet
E. Artime
,
Irene Shui
,
+4 authors
N. Qizilbash
Pharmacoepidemiology and Drug Safety
2020
Corpus ID: 204969924
The alglucosidase alfa (Myozyme®) Safety Information Packet (“previous SIP”) was updated to improve readability and content…
Expand
2015
2015
Pompe disease, acid alpha glucosidase, hypotonia, myozyme.
N. Jeergal
,
Rizwan-u-zama
,
N. Malagi
2015
Corpus ID: 87311551
2013
2013
Vitamin K antagonists are hard to beat by the price - are they? Some answers, new questions and the GPs dilemma.
J. Beer
Swiss medical weekly
2013
Corpus ID: 27614080
With dabigatran and rivaroxaban, two new promising anticoagulants (NOACs) are now approved and available in most countries…
Expand
2013
2013
Ureterolithotripsy under Spinal Anesthesia in Pompe Disease (Glycogen Storage Disease Type 2): A Case Report
A. Acar
,
M. Deniz
,
E. Erhan
,
G. Ugur
2013
Corpus ID: 40429593
Pompe disease is an autosomal recessive inherited glycogen storage disease, usually respiratory muscles, cardiac muscle and…
Expand
2012
2012
Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease.
M. I. Nilsson
,
Imtiaz A. Samjoo
,
+11 authors
M. Tarnopolsky
Molecular Genetics and Metabolism
2012
Corpus ID: 40334291
2012
2012
Muscling up on Myozyme
T. Fulmer
2012
Corpus ID: 71474976
Oxyrane and BioMarin have separately reported on their next-generation enzyme replacement therapies for Pompe's disease. Both…
Expand
2012
2012
A wise and just decision, comment on the swiss supreme court ruling on myozyme
S. Felder
2012
Corpus ID: 155827492
Review
2009
Review
2009
Phenotype variations in early onset Pompe disease: diagnosis and treatment results with Myozyme.
S. I. Pascual
Advances in Experimental Medicine and Biology
2009
Corpus ID: 26003139
Pompe disease is a rare autosomal recessive lysosomal storage disease caused by deficiency of acid-a-glucosidase (GAA). This…
Expand
2007
2007
Patients, profi ts and values: Myozyme as an exemplar of biosociality
C. Novas
2007
Corpus ID: 187993030
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required